SCHEMBL7763429

SCHEMBL7763429

CC(C)(C)ON(C=O)Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.41
AKT1 P31749 2/20 0.39
RIPK1 Q13546 2/20 0.39
AOC3 Q16853 1/20 0.38
RAB9A P51151 3/20 0.37
NPC1 O15118 2/20 0.37
CA12 O43570 1/20 0.37
CA9 Q16790 1/20 0.37
CYP2C19 P33261 1/20 0.36
RECQL P46063 1/20 0.36
LMNA P02545 1/20 0.36
CTSL P07711 1/20 0.35
CTSB P07858 1/20 0.35
CTSS P25774 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL403826 0.90 TAAR1 (0.47) HTTTSHRLMNA
SCHEMBL5780510 0.83 ALDH1A1 (0.38) KMT2AALDH1A1RAB9ALMNA
SCHEMBL643420 0.83 MAPT (0.38) ALDH1A1TSHRRAB9ANPC1
SCHEMBL6949347 0.83 TAAR1 (0.44) MEN1KMT2AHTTL3MBTL1AOC3
SCHEMBL5662615 0.83 LOXL2 (0.35) CA12CA9
SCHEMBL11503093 0.82 RXRA (0.41) HTTALDH1A1TSHRLMNACTSB
SCHEMBL5603701 0.82 ALDH1A1 (0.43) KMT2AALDH1A1RAB9ANPC1
SCHEMBL5663890 0.81 LOXL2 (0.38) ALDH1A1RIPK1AOC3
SCHEMBL7662463 0.81 S1PR1 (0.39) RIPK1
SCHEMBL4518626 0.81 HSD11B1 (0.38) ALDH1A1RIPK1AOC3CA9RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110300578-A For treating the compound of ox or porcine respiratory disease 英特维特国际股份有限公司 2019-10-01 CN disclosed
CN-110072844-A Compounds for the treatment of infections with Mannheim haemolytica or histophilus somni 英特维特国际股份有限公司 2019-07-30 CN disclosed
EP-0821665-B1 CYCLOBUTANE DERIVATIVES AS INHIBITORS OF SQUALENE SYNTHASE AND PROTEIN FARNESYLTRANSFERASE ABBOTT LAB (US) 2001-10-04 EP disclosed
EP-1090908-A2 Cyclobutane derivatives as inhibitors of protein farnesyltransferase ABBOTT LABORATORIES (US) 2001-04-11 EP disclosed
US-5831115-A CYCLOBUTANECARBOXAMIDES ABBOTT LABORATORIES (US) 1998-11-03 US disclosed
EP-0821665-A1 CYCLOBUTANE DERIVATIVES AS INHIBITORS OF SQUALENE SYNTHASE AND PROTEIN FARNESYLTRANSFERASE Abbott Laboratories (US) 1998-02-04 EP disclosed
US-5631401-A Inhibitors of protein farnesyltransferase and squalene synthase ABBOTT LABORATORIES (US) 1997-05-20 US disclosed
WO-1996033159-A1 CYCLOBUTANE DERIVATIVES AS INHIBITORS OF SQUALENE SYNTHASE AND PROTEIN FARNESYLTRANSFERASE ABBOTT LABORATORIES (US) 1996-10-24 WO disclosed
WO-1995021815-A1 CYCLOBUTANE DERIVATIVES AND THEIR USE AS INHIBITORS OF PROTEIN FARNESYLTRANSFERASE AND SQUALENE SYNTHASE ABBOTT LABORATORIES (US) 1995-08-17 WO disclosed